Home
Home

bloodthinners

Bayer, J&J’s Xarelto Wins EU Backing for Expanded Use

Bayer, J&J’s Xarelto Wins EU Backing for Expanded Use
Bloomberg

How AstraZeneca Will Use A Diagnostic To Market Its Blood Thinner

How AstraZeneca Will Use A Diagnostic To Market Its Blood Thinner
Forbes

J&J, Bayer Fail to Win U.S. Backing for Expanded Xarelto

J&J, Bayer Fail to Win U.S. Backing for Expanded Xarelto
Bloomberg

Armed with EU stroke approval, Pfizer, BMS talk up Eliquis' edge over rivals

Armed with EU stroke approval, Pfizer, BMS talk up Eliquis' edge over rivals
Fierce Pharma

FDA to decide by March on Pfizer/Bristol blood thinner

FDA to decide by March on Pfizer/Bristol blood thinner
Reuters

Bayer, J&J answer FDA query over wider Xarelto use

Bayer, J&J answer FDA query over wider Xarelto use
Reuters

Merck will seek approval of 2 heart drugs in 2013

Merck will seek approval of 2 heart drugs in 2013
Yahoo/AP

Bayer’s Xarelto Helped Survival After Heart Attack: Study

Bayer’s Xarelto Helped Survival After Heart Attack: Study
Bloomberg

Blood-thinner Pradaxa target of mass-claims suit

Blood-thinner Pradaxa target of mass-claims suit
USA Today

AstraZeneca Expands Study Of Brilinta Against Plavix

AstraZeneca Expands Study Of Brilinta Against Plavix
Bloomberg